Skip to main content
. Author manuscript; available in PMC: 2015 Feb 2.
Published in final edited form as: Cancer. 2010 Jul 1;116(13):3152–3159. doi: 10.1002/cncr.25071

Table 5.

Imatinib Dose at 48 Months Follow-up by Pre-Existing Organ Function

Imatinib Evaluable Patient Imatinib Dose at 48 Months, No. (%)
300 mg 400 mg 600 mg 800 mg
400 mg Renal dysfunction (n=2) 0 (0) 1 (50) 0 (0) 1 (50)
Liver dysfunction (n=4) 0 (0) 4 (100) 0 (0) 0 (0)
Normal (n=26) 3 (11) 22 (85) 1 (4) 0 (0)
800 mg Renal dysfunction (n=6) 1 (17) 2 (33) 2 (33) 1 (17)
Liver dysfunction (n=21) 0 (0) 2 (10) 5 (24) 14 (66)
Normal (n=122) 3 (3) 20 (16) 33 (27) 66 (54)